Blog
RSS FeedPosted by Michael Wonder on 27 Apr 2023
CADTH, ICER, and NICE release joint position statement on redacting clinical data awaiting publication
24 April 2023 - The position statement is a step toward greater transparency of unpublished data and a tangible outcome ...
Posted by Michael Wonder on 24 Apr 2023
NICE collaborates with international partner agencies to streamline the confidential marking process
24 April 2023 - NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and ...
Posted by Michael Wonder on 30 Mar 2023
Clarity around PHARMAC’s priority lists
30 March 2023 - PHARMAC released its first Clarity Report, containing the latest information about medicines, vaccines, and related products ...
Posted by Michael Wonder on 13 Oct 2022
Clarity around PHARMAC’s priority lists (October 2022)
13 October 2022 - In March 2022, PHARMAC released its first Pūahoaho (clarity) Report, containing the latest information about its ...
Posted by Michael Wonder on 04 Oct 2022
2022 October price disclosure cycle – confirmed prices and patient savings reports
1 October 2022 - Combination flow-on reduction outcomes reflect confirmed 1 October 2022 prices on the Current Price Disclosure cycle web ...
Posted by Michael Wonder on 04 Jul 2022
2022 October price disclosure cycle – indicative prices
4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 26 Jun 2022
Price disclosure 2022 October cycle outcomes summary
24 June 2022 - The summary of price disclosure price reductions for the 2022 October Cycle has now been published on ...
Posted by Michael Wonder on 08 Jun 2022
Updated price disclosure guidelines, price disclosure webpages and price disclosure dispute resolution process
8 June 2022 - Amendments made to the National Health Act 1953 and National Health (Pharmaceutical Benefits) Regulations 2017 by the ...
Posted by Michael Wonder on 31 Mar 2022
2022 April cycle - brand price reductions and savings to patients
31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have ...
Posted by Michael Wonder on 15 Mar 2022
1 April 2022 price disclosure confirmed prices
15 March 2022 - Confirmed 1 April 2022 prices resulting from the 2022 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 09 Mar 2022
Pūahoaho: clarity around PHARMACs priority lists
9 March 2022 - PHARMAC has released up to date information about its priority lists, including a list of ...
Posted by Michael Wonder on 26 Feb 2022
COVID-19 vaccines: individual patient data should be submitted to the European Medicines Agency
24 February 2022 - An interesting letter to the Editor of the BMJ from the Head of Drug Assessment at ...
Posted by Michael Wonder on 27 Jan 2022
2022 April price disclosure cycle – indicative prices
27 January 2022 - Indicative 1 April 2022 prices resulting from the 2022 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 10 Dec 2021
Price disclosure 2022 April cycle outcomes summary
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...
Posted by Michael Wonder on 13 Sep 2021
1 October 2021 price disclosure confirmed prices
13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...